Healthcare Providers

PathLabs - Medical Testing Laboratory

Publications

Home | Healthcare Providers | Publications

 

Search by :

 

 
Occult Blood, Fecal, Immunoassay (iFOBT) Test 12/11/2012 Client Communications

Fecal Occult Blood Testing by Immunoassay (iFOBT) is now being performed in-house.
cobas HPV Test 12/27/2012 Client Communications

Beginning in early January 2013 HPV testing of ThinPrep specimens will be performed using the FDA-approved, real-time PCR cobas method.
QualityQues Fall 2012 12/13/2012 Newsletters
  • Laboratory Testing When Screening for Hypo- and Hyperthyroidism
  • Susceptibility Testing
  • Trichomonas Testing by NAA
  • ABN for Pap Screening
  • Urine Transport Tubes
  • Pathology Laboratories' Website
QualityQues Spring 2012 05/30/2012 Newsletters
  • Custom Panels
  • Specimen Pickup Confirmation Numbers
  • Women's Health Testing
  • MedTox Drug Testing
  • Patient Information Sheets:  Lead and QUAD Screen Testing
  • Lower Fees
  • New Occult Blood Testing
QualityQues Fall 2011 11/30/2011 Newsletters
  • Communication is Critical
  • PECOS Enrollment for Ordering/Referring Providers of Laboratory Services
  • Revised Advanced Beneficiary Notice Version 03/11
  • Clostridium difficile Testing
  • ImmunoCAP Allergen Testing
  • HPV Testing
  • Interface Update/Practice Fusion
Clostridium difficile Testing 08/15/2011 Client Communications

In-house testing is now available for Clostridium difficile toxins by molecular DNA assay.  

Specimen Labeling: Two (2) Patient Identifiers Required 12/15/2010 Client Communications

College of American Pathologists' (CAP) standards require all submitted specimens be labeled with two (2) patient identifiers.
Breast Biopsies - ASCO/CAP Guidelines 02/15/2011 Client Communications

PathLabs is pleased to offer breast biopsy readings by noon the following day.  Breast biopsies must be in formalin a minimum of 6 hours, not to exceed 48 hours, to ensure accurate results of receptor and HER-2/neu studies.

QualityQues Fall 2010 10/01/2010 Newsletters
  • Medicare Approved ICD-9CM Codes for National Coverage Determinations (NCD)
  • GFR Reporting
  • QUAD Testing
  • Patient Identifiers
  • New Microbiology Collection Flyer Available
  • Expiration Dates on Supplies
  • Changes to Critical and Alert Levels
  • Welcome to Our New Pathologist, Amber L. Patton, D.O.
  • LabCalls® Program Offered for Release of Pap Test Results
QualityQues Summer 2011 06/14/2011 Newsletters
  • Retesting of Positive Chlamydia/Neisseria Gonorrhoeae (Test of Cure)
  • Changes in Local Coverage Determinations (LCDs) for Laboratory Services in Ohio
  • Sed Rate Specimen Type Change
  • Advantages and Disadvantages of Winged Infusion Sets "Butterfly Sets"
  • Supply Ordering Made Easy
  • CervistaTM HPV 16/18
Page 1 of 4
<<first | prev | 1 2 3 4 | next | last>>